Conducted by The George Institute for Global Health in collaboration with Blacktown, Concord and Campbelltown hospitals and the Woolcock Institute for Medical Research, the study wants to enrol 100 current smokers who have smoked for 10 years or more, with no symptoms as yet of lung disease. Details: woolcock.org.au/ecos.
Smokers wanted for trial
SMOKERS aged 25-55 are needed for a trial of a new product which aims to slow lung function decline in smokers and reduce rates of chronic obstructive pulmonary disease (COPD).
